Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLGW) Invested Capital (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Invested Capital for 2 consecutive years, with $2.7 million as the latest value for Q3 2017.

  • Quarterly Invested Capital rose 33.42% to $2.7 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Sep 2017, up 33.42% year-over-year, with the annual reading at -$7.2 million for FY2016, N/A changed from the prior year.
  • Invested Capital for Q3 2017 was $2.7 million at Bone Biologics, up from $2.5 million in the prior quarter.
  • The five-year high for Invested Capital was $5.8 million in Q1 2016, with the low at -$7.2 million in Q4 2016.